ASTRO’s Sanha Diagnosed With COVID-19 After Suddenly Halting Comeback Promotions Due To Health
On the afternoon of January 8, ASTRO’s agency Fantagio announced that because Sanha’s health had suddenly taken a turn for the worse, he would not be able to participate in his scheduled activities for Moonbin&Sanha’s unit comeback.
ASTRO’s Moonbin, who is currently promoting together [with Sanha], also underwent a rapid antigen test, and his test results came back negative. Therefore, it will be difficult for ASTRO’s Yoon Sanha to participate in his scheduled activities, and we will make another announcement in the future about our artist’s return to activities after we confirm the time at which his mandatory quarantine will end.
Furthermore, the video call and fan signing events for the release of Moonbin&Sanha’s third mini album “” that were scheduled to take place on Thursday, January 12 and Saturday, January 14 will be postponed; and the radio appearances on MBC FM4U’s “GOT7’s Youngjae’s Close Friend” and KBS Cool FM’s “BTOB’s Kiss the Radio” have been cancelled.
We ask for your understanding in regards to the fact that we have given many people cause for concern. We will continue to consider the health of our artists and staff our top priority, and we will do our utmost for the speedy recovery of our artist while adhering to the guidelines of government health authorities.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
As COVID ravages China, US expands testing system for incoming travelersThe U.S. is expanding its COVID-19 testing system. Travelers arriving to the states will now be able to voluntarily and anonymously take tests that track new variants.
Read more »
NY Fed says China's COVID woes are pressuring supply chainsDeclining world supply chain pressures are being challenged by new disruptions in China tied to the coronavirus pandemic, the New York Federal Reserve reported on Friday.
Read more »
AstraZeneca's COVID drug Evusheld unlikely to neutralize newest variant, FDA saysThe Food and Drug Administration late Friday said that AstraZeneca Plc's undefined COVID-19 drug Evusheld may not provide protection against developing the...
Read more »
Most Long COVID Cases Started With Mild Symptoms: Study“We found that a staggering 90% of people living with long COVID initially experienced only mild illness with COVID-19,” researchers say.
Read more »
COVID hospitalizations, deaths could rise in coming weeks, according to the CDCNew CDC data and ensemble forecasts suggest COVID-19 hospitalizations and deaths could be on the rise in the next few weeks; meanwhile, the new XBB subvariants are considered more 'immuno-evasive.'
Read more »
New COVID subvariant XBB.1.5 is 'most transmissible' yetSingapore was hit hard by the new variant, which is very contagious, but the number of hospitalizations didn't rise. – via healthing_ca COVID19 Omicron HealthNews
Read more »